help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schramm, C. M.
Right arrow Articles by Thrall, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schramm, C. M.
Right arrow Articles by Thrall, R. S.
(American Journal of Pathology. 2004;164:295-304.)
© 2004 American Society for Investigative Pathology

Chronic Inhaled Ovalbumin Exposure Induces Antigen-Dependent but Not Antigen-Specific Inhalational Tolerance in a Murine Model of Allergic Airway Disease

Craig M. Schramm*, Lynn Puddington{dagger}, Carol Wu{dagger}, Linda Guernsey{dagger}, Mehrnaz Gharaee-Kermani{ddagger}, Sem H. Phan§ and Roger S. Thrall{dagger}

From the Departments of Pediatrics* and Medicine,{dagger} Pulmonary Research Consortium, University of Connecticut School of Medicine, Farmington, Connecticut; the Department of Internal Medicine,{ddagger} University of Michigan Medical School, Ann Arbor, Michigan; and the Department of Pathology,§ University of Michigan, Ann Arbor, Michigan

Sensitized mice acutely challenged with inhaled ovalbumin (OVA) develop allergic airway inflammation, characterized by OVA-specific IgE production, airway eosinophilia, increased pulmonary B and T lymphocytes, and airway hyperreactivity. In this study, a chronic exposure model was developed and two distinct patterns of response were observed. Discontinuous inhalational exposure to OVA (6 weeks) produced airway inflammation and hyperreactivity that were similar to acute (10 days) responses. Continuous inhalational exposure to OVA (6 or 11 weeks) resulted in attenuation of airway eosinophilia and hyperresponsiveness without reduction of OVA-specific IgE and IgG1 levels. The inhibition of airway inflammation was dependent on continuous exposure to antigen, because continuously exposed mice with attenuated inflammatory responses redeveloped allergic airway disease if the OVA aerosols were interrupted and then restarted (11-week-discontinuous). Inhalational tolerance induced by continuous OVA exposure demonstrated bystander suppression of cockroach allergen-mediated airway eosinophilia. These findings may be attributed to changes in production of the anti-inflammatory cytokine interleukin-10 during continuous OVA aerosol exposure. The symptomatic and asymptomatic allergic responses in human asthmatics could be explained by similar variable or discontinuous exposures to aeroantigens.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
A. Singh, W. F. Carson IV, E. R. Secor Jr, L. A. Guernsey, R. A. Flavell, R. B. Clark, R. S. Thrall, and C. M. Schramm
Regulatory Role of B Cells in a Murine Model of Allergic Airway Disease
J. Immunol., June 1, 2008; 180(11): 7318 - 7326.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. P. Matson, L. Zhu, E. G. Lingenheld, C. M. Schramm, R. B. Clark, D. M. Selander, R. S. Thrall, E. Breen, and L. Puddington
Maternal Transmission of Resistance to Development of Allergic Airway Disease
J. Immunol., July 15, 2007; 179(2): 1282 - 1291.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Niu and L. Cohn
Response to Comment on "A Novel Pathway That Regulates Inflammatory Disease in the Respiratory Tract"
J. Immunol., June 15, 2007; 178(12): 7501 - 7502.
[Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. L. Van Hove, T. Maes, G. F. Joos, and K. G. Tournoy
Prolonged Inhaled Allergen Exposure Can Induce Persistent Tolerance
Am. J. Respir. Cell Mol. Biol., May 1, 2007; 36(5): 573 - 584.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Niu, M. K. Le Goff, F. Li, M. Rahman, R. J. Homer, and L. Cohn
A Novel Pathway That Regulates Inflammatory Disease in the Respiratory Tract
J. Immunol., March 15, 2007; 178(6): 3846 - 3855.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. Tigani, C. Cannet, H. Karmouty-Quintana, F.-X. Ble, S. Zurbruegg, E. Schaeublin, J. R. Fozard, and N. Beckmann
Lung inflammation and vascular remodeling after repeated allergen challenge detected noninvasively by MRI
Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L644 - L653.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Pierce, J. Rir-Sima-Ah, I. Estrada, J. Wilder, A. Strasser, and Y. Tesfaigzi
Loss of pro-apoptotic Bim promotes accumulation of pulmonary T lymphocytes and enhances allergen-induced goblet cell metaplasia
Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L862 - L870.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Jin, C. Taube, L. Sharp, Y.-S. Hahn, X. Yin, J. M. Wands, C. L. Roark, R. L. O'Brien, E. W. Gelfand, and W. K. Born
Mismatched Antigen Prepares {gamma}{delta} T Cells for Suppression of Airway Hyperresponsiveness
J. Immunol., March 1, 2005; 174(5): 2671 - 2679.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.